The present invention relates to the use of BACE-2 inhibitors and pharmaceutical compositions comprising BACE-2 inhibitors for treating metabolic disorders related to decreased β cell mass and/or function.La presente invención se refiere al uso de inhibidores de BACE-2 y composiciones farmacéuticas que comprenden inhibidores de BACE-2 para tratar trastornos metabólicos relacionados con masa y/o función reducida de célula ß.